Skip to Content

WPI 867 (Bupropion Hydrochloride Extended-Release (SR) 150 mg)

Pill with imprint WPI 867 is White, Round and has been identified as Bupropion Hydrochloride Extended-Release (SR) 150 mg. It is supplied by Watson Pharmaceuticals.

Bupropion is used in the treatment of major depressive disorder; depression; seasonal affective disorder; smoking cessation and belongs to the drug classes miscellaneous antidepressants, smoking cessation agents. Risk cannot be ruled out during pregnancy. Bupropion 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 867

Bupropion hydrochloride extended-release (SR) 150 mg WPI 867
Bupropion hydrochloride extended-release (SR) 150 mg WPI 867 Front
Bupropion hydrochloride extended-release (SR) 150 mg WPI 867 Back
Bupropion hydrochloride extended-release (SR) 150 mg WPI 867
Bupropion hydrochloride extended-release (SR) 150 mg WPI 867

Bupropion Hydrochloride Extended-Release (SR)

Imprint
WPI 867
Strength
150 mg
Color
White
Shape
Round
Availability
Prescription only
Drug Class
Miscellaneous antidepressants, Smoking cessation agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Pharmaceuticals
National Drug Code (NDC)
00591-0867

Get help with Imprint Code FAQs.

Related Images for "WPI 867"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.